CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM NEW
Total 13F shares
449,198
Share change
+67,189
Total reported value
$454,000
Price per share
$1.02
Number of holders
10
Value change
+$66,282
Number of buys
7
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q3 2019

As of 30 Sep 2019, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 449,198 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, National Asset Management, Inc., ROYAL BANK OF CANADA, UBS Group AG, VICTORY CAPITAL MANAGEMENT INC, and BlackRock Inc.. This page lists 10 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.